With more than $1 billion in facility-specific investment and more than 500 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). It is also confirmed by official public sources and involves a physical manufacturing facility in the United States.
View full methodology →The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
At a glance
- Company
- Johnson & Johnson (Innovative Medicine)
- Industry
- Pharmaceuticals
- Location
- Lower Gwynedd Township, Pennsylvania
- Investment
- More than $1.00B
- Permanent jobs announced
- More than 500
- Status
- Planning
- Announced
- Feb 18, 2026
- Expected opening
- 2031
- Added to tracker
- Sep 1, 2026
Official references
- Johnson & Johnson's February 18, 2026 Lower Gwynedd cell-therapy announcement https://www.jnj.com/media-center/press-releases/johnson-johnson-expands-u-s-footprint-with-more-than-1-billion-investment-in-next-generation-cell-therapy-manufacturing-facility-in-pennsylvania
- Commonwealth of Pennsylvania announcement of the Johnson & Johnson investment and state support https://www.pa.gov/governor/newsroom/2026-press-releases/icymi--pennsylvania-surpasses--40-billion-in-private-sector-inve
Cite this project
American Factory Tracker. "Lower Gwynedd Cell Therapy Manufacturing Facility — Johnson & Johnson, Lower Gwynedd Township, PA." https://americanfactorytracker.com/projects/johnson-johnson-lower-gwynedd-cell-therapy-manufacturing. Accessed November 4, 2026.
Please also cite the original sources listed above for underlying figures.